These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
619 related items for PubMed ID: 12143052
1. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma. Roncalli M, Bianchi P, Bruni B, Laghi L, Destro A, Di Gioia S, Gennari L, Tommasini M, Malesci A, Coggi G. Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052 [Abstract] [Full Text] [Related]
2. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma. Peng CY, Chen TC, Hung SP, Chen MF, Yeh CT, Tsai SL, Chu CM, Liaw YF. Anticancer Res; 2002 Aug; 22(2B):1265-71. PubMed ID: 12168936 [Abstract] [Full Text] [Related]
3. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma. Furonaka O, Takeshima Y, Awaya H, Ishida H, Kohno N, Inai K. Pathol Int; 2004 Aug; 54(8):549-55. PubMed ID: 15260845 [Abstract] [Full Text] [Related]
4. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C. Oncogene; 2001 Oct 25; 20(48):7104-9. PubMed ID: 11704835 [Abstract] [Full Text] [Related]
5. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status. Chaussade L, Eymin B, Brambilla E, Gazzeri S. Oncogene; 2001 Oct 04; 20(45):6587-96. PubMed ID: 11641784 [Abstract] [Full Text] [Related]
6. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma. Chinnasri P, Pairojkul C, Jearanaikoon P, Sripa B, Bhudhisawasdi V, Tantimavanich S, Limpaiboon T. Hum Pathol; 2009 Jun 04; 40(6):817-26. PubMed ID: 19200577 [Abstract] [Full Text] [Related]
7. Promoter hypermethylation of p14 (ARF) , RB, and INK4 gene family in hepatocellular carcinoma with hepatitis B virus infection. Zhang JC, Gao B, Yu ZT, Liu XB, Lu J, Xie F, Luo HJ, Li HP. Tumour Biol; 2014 Mar 04; 35(3):2795-802. PubMed ID: 24254306 [Abstract] [Full Text] [Related]
8. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Edmunds SC, Kelsell DP, Hungerford JL, Cree IA. Invest Ophthalmol Vis Sci; 2002 Sep 04; 43(9):2845-51. PubMed ID: 12202501 [Abstract] [Full Text] [Related]
9. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer. Ishiguro A, Takahata T, Saito M, Yoshiya G, Tamura Y, Sasaki M, Munakata A. J Gastroenterol Hepatol; 2006 Aug 04; 21(8):1334-9. PubMed ID: 16872319 [Abstract] [Full Text] [Related]
10. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer. Kurakawa E, Shimamoto T, Utsumi K, Hirano T, Kato H, Ohyashiki K. Int J Oncol; 2001 Aug 04; 19(2):277-81. PubMed ID: 11445839 [Abstract] [Full Text] [Related]
11. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas. Nakamura M, Sakaki T, Hashimoto H, Nakase H, Ishida E, Shimada K, Konishi N. Cancer Res; 2001 Sep 01; 61(17):6335-9. PubMed ID: 11522621 [Abstract] [Full Text] [Related]
12. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM. Mol Carcinog; 2002 Oct 01; 35(2):85-92. PubMed ID: 12325038 [Abstract] [Full Text] [Related]
13. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma. Hutter G, Scheubner M, Zimmermann Y, Kalla J, Katzenberger T, Hübler K, Roth S, Hiddemann W, Ott G, Dreyling M. Genes Chromosomes Cancer; 2006 Feb 01; 45(2):203-10. PubMed ID: 16258956 [Abstract] [Full Text] [Related]
14. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas. Kirsch M, Mörz M, Pinzer T, Schackert HK, Schackert G. Genes Chromosomes Cancer; 2009 Feb 01; 48(2):143-54. PubMed ID: 18973139 [Abstract] [Full Text] [Related]
15. p16 is a major inactivation target in hepatocellular carcinoma. Jin M, Piao Z, Kim NG, Park C, Shin EC, Park JH, Jung HJ, Kim CG, Kim H. Cancer; 2000 Jul 01; 89(1):60-8. PubMed ID: 10897001 [Abstract] [Full Text] [Related]
16. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc. Haviernik P, Schmidt M, Hu X, Wolff L. Oncogene; 2003 Mar 20; 22(11):1600-10. PubMed ID: 12642863 [Abstract] [Full Text] [Related]
17. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas. Ito T, Nishida N, Fukuda Y, Nishimura T, Komeda T, Nakao K. J Gastroenterol; 2004 Mar 20; 39(4):355-61. PubMed ID: 15168247 [Abstract] [Full Text] [Related]
18. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma. Kanellou P, Zaravinos A, Zioga M, Spandidos DA. Br J Dermatol; 2009 Jun 20; 160(6):1215-21. PubMed ID: 19298278 [Abstract] [Full Text] [Related]
19. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Schagdarsurengin U, Wilkens L, Steinemann D, Flemming P, Kreipe HH, Pfeifer GP, Schlegelberger B, Dammann R. Oncogene; 2003 Mar 27; 22(12):1866-71. PubMed ID: 12660822 [Abstract] [Full Text] [Related]
20. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma. Chim CS, Wong KY, Loong F, Lam WW, Srivastava G. Hum Pathol; 2007 Dec 27; 38(12):1849-57. PubMed ID: 17900658 [Abstract] [Full Text] [Related] Page: [Next] [New Search]